Objectway Accelerates Its Growth Path Through an Investment From Cinven in Partnership With Its Founder Luigi Marciano and the Existing Management Team
Luigi Marciano, founder of Objectway, a leading provider of software and services to financial institutions across Europe, North America and the Middle East, along with Objectway’s management team and international private equity firm, Cinven, today announced an agreement under which Cinven will make a majority investment in Objectway. Luigi Marciano will remain a significant shareholder alongside Cinven, and continue in his role as CEO and Chair. He and his existing management team will continue to manage the business, and Cinven’s backing will provide strategic and financial support, including continued investment in technology innovation, as well as support for future organic growth and targeted M&A opportunities. Together, Luigi Marciano, his team and Cinven aim to expand Objectway’s market leadership while delivering consistently high value to clients. Financial terms of the investment are not disclosed.
Objectway is a leading digital end-to-end “Solution-as-a-Service” provider for wealth managers, banks and asset managers. Objectway provides customers with a mission-critical, modular, front-to-back office software and solutions platform, delivered through a flexible design based on scalable cloud infrastructure. Founded in 1990 and headquartered in Milan, Objectway supports more than 250 financial institutions across more than 16 countries. With offices across Europe and North America, Objectway combines mission-critical technology and services with deep domain expertise.
The wealth management ecosystem is exhibiting consistent growth and strong demand for investment in modern technology solutions from established providers, presenting opportunities to digitise the industry and capture market share. Industry trends include the need to transition from fragmented legacy systems to integrated end-to-end solutions that create efficiency in front-to-back office processes, serving clients consistently, across the value chain, geographies, and investor segments.
Cinven believes that Objectway is a compelling primary investment opportunity based on a number of attractive characteristics, including its:
- Well-established position in a structurally growing market: Outsourced technology and tech-enabled services spend across the wealth management, banking and asset management industries is expected to grow strongly, driven by increasing regulatory complexity, customer demand for digital solutions, and the continued focus of customers on protecting margins;
- Differentiated offering: Objectway has a differentiated end-to-end front, middle and back-office platform offering across a wide-spectrum of wealth management customer types. Objectway has consistently been selected by many of the world's wealth managers, private banks, asset managers and asset services as their digital wealth platform for its thoughtful and innovative product roadmap, which integrates client feedback, regulatory requirements, technological advancements, and evolving market dynamics;
- Attractive and resilient business model: Objectway has highly recurring revenues and earnings visibility and strong cash flow generation, driven by its blue-chip customer base and growing “Solution-as-a-Service” delivery model;
- Multiple further growth and value creation levers: With Cinven’s financial and strategic support, there are significant further growth opportunities for the business, including through organic growth, targeted M&A, and accelerated investment into the technology platform; and
- Strong founder-led management team: Opportunity to partner with a strong and experienced management team led by its founder, CEO and Chair, Luigi Marciano, for the next stage of the company’s growth.
This transaction represents the first investment from Cinven’s new mid-market strategy. The European mid-market is an investment space where Cinven has deep expertise and networks to draw on, particularly in areas aligned with the firm’s core geographic and sector strengths, including across technology and tech-enabled services, financial services and business services.
Luigi Marciano, CEO, Chair and founder of Objectway said:
"Partnering with Cinven marks an exciting new chapter for Objectway. Their investment is a strong endorsement of our business model, our leadership team, and our long-term growth plan. Together, we’re well-positioned to accelerate our expansion, further strengthen our market position, accelerate the enhancement of our platform, and continue delivering exceptional value to our customers and to the market."
Luigi Sbrozzi, Partner and Co-Head of the Strategic Funds at Cinven said:
“We believe that Cinven makes an excellent partner to help Luigi Marciano and the wider management team achieve their bold growth ambitions. Cinven has a wealth of experience in the financial services and technology sectors, and a successful track record of partnering with exceptional management teams to create market leading businesses by investing for growth, including through tech-led innovation and buy and build strategies. We’re thrilled to back such a strong founder and management team to grow Objectway as a clear category leader, and look forward to working together to accelerate growth, broaden capabilities, and support global expansion.”
Advisors to Objectway on the transaction included Houlihan Lokey as financial advisor and Deloitte for strategic consulting on the business plan, as well as financial, commercial, and technical due diligence. PwC advised on tax and legal due diligence. Giovannelli Associati acted as the legal advisor and Russo De Rosa Associati as the tax advisor.
Cinven was advised by Jefferies (M&A), Freshfields (Legal), PwC (Financial), Alix Partners (Technology & Operations), Oliver Wyman (Commercial) and Deloitte (Tax and Structuring).
The transaction is subject to regulatory approvals and other customary closing conditions.
About Objectway
For more than 30 years, Objectway has been building successful partnerships with banking, asset and wealth management firms to empower and scale their business with a broader societal objective: preserve capital and improve the financial wellbeing of their clients.
Objectway offers a leading as-a-service growth platform for banks, wealth & asset managers and their investors. The Objectway platform provides these financial institutions with superior scalability for greater performance to empower their entire value chain.
Objectway’s end-to-end solution design allows its customers to be serviced consistently within both a local and international setting, underpinned by 24-7 secure infrastructure.
As a global Top 100 FinTech provider (IDC FinTech Rankings), Objectway administers more than €1 trillion of assets and supports more than 100,000 investment professionals (financial advisers, private bankers, relationship managers) to manage more than €800 billion of asset under management for more than 5 million investors. FY 2024 revenue exceeded €120 million and clients include more than 250 leading banks, wealth managers, asset managers and insurers across Europe, the Middle East and Canada.
Objectway has a global organisation including more than 800 business and technology professionals, with operating offices in Italy, the UK, Belgium, Germany, Switzerland, France, Ireland, and Canada.
Objectway’s flexible solution design addresses global and regional organisation structures across jurisdictions. Scale generates scale through expansion across customers, geographies and along the value chain.
About Cinven
Cinven is a leading international private equity firm focused on building world-class global and European companies. Its funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials and Technology, Media and Telecommunications (TMT). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid, Guernsey and Luxembourg.
Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society.
Cinven Limited is authorised and regulated by the Financial Conduct Authority. Cinven Fund Management S.à r.l. is authorised and regulated by the Commission de Surveillance du Secteur Financier.
In this press release ‘Cinven’ means, depending on the context, any of or collectively, Cinven Holdings Guernsey Limited, Cinven Partnership LLP, and their respective Associates (as defined in the Companies Act 2006) and/or funds managed or advised by any of the foregoing.
For additional information on Cinven please visit www.cinven.com and www.linkedin.com/company/cinven/.
COPYRIGHT © 2025 OBJECTWAY GROUP
View source version on businesswire.com: https://www.businesswire.com/news/home/20250801371668/en/
Contacts
Contact – Objectway
Chiara Giudici
Communication Manager
+39 393 8229579
chiara.giudici@objectway.com
objectway.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.objectway.c
om%2F&esheet=54301675&newsitemid=20250801371668&lan=en-US&anchor=objectway.com&i
ndex=3&md5=6067f29f27d04d6761b8b4a2fa533c62
Marketing Team (Objectway)
mktg@objectway.com
Contact – Cinven
Clare Bradshaw
Tel. +44 (0)7881 918 967
Email. clare.bradshaw@cinven.com
Alison Raymond
Tel. +44 (0)7826 856198
Email. alison.raymond@cinven.com
Brunswick Group (Advisers to Cinven)
Joanna Donne
Cinven@Brunswickgroup.com
Tel. +44 (0)7834 307 881
Email. jdonne@brunswickgroup.com
Max McGahan
Tel. +44 (0) 7834 502369
Email. mmcgahan@brunswickgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 19:00:00 EEST | Press release
Daiichi Sankyo Europe is pleased to announce the initiation of the development of new oral triple combination tablets in Europe of bempedoic acid, ezetimibe, and different doses of a statin (atorvastatin or rosuvastatin), with the potential to lower low-density lipoprotein cholesterol (LDL-C) levels.9 It is well known that combination therapies reduce the pill burden for patients, potentially enhancing treatment adherence and facilitating treatment with a goal of improving cardiovascular outcomes.9,10 “As bempedoic acid and ezetimibe are already approved as a single-dose therapy, the development of an oral triple combination tablet with different doses of a statin, can make it easier for physicians to tailor treatment to the individual needs of each patient,” says Dr. Stefan Seyfried, Vice President and Head Medical Affairs Specialty Medicines, Daiichi Sankyo Europe. “This approach exemplifies our dedication to our motto: ‘we care for every heartbeat’.” “The management of dyslipidaemia
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 17:30:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from the comprehensive KARDIA Phase 2 program, including KARDIA-3 results presented today as a late-breaking abstract at the European Society of Cardiology (ESC) Congress in Madrid, Spain. Zilebesiran is an investigational subcutaneously administered RNAi therapeutic which, in the KARDIA Phase 2 program, has shown reductions in blood pressure by targeting liver-expressed angiotensinogen (AGT), the most upstream precursor in the Renin-Angiotensin-Aldosterone System (RAAS), which plays a key role in blood pressure regulation and impacts cardiovascular and renal health. KARDIA-3, the third Phase 2 study in the KARDIA program, evaluated the efficacy and safety of zilebesiran in patients with
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and durable responses and offer the first BCL2 inhibitor for patients with R/R MCL, if approved,” said Lai Wang, PhD, Global Head of R&D, BeOne Medicines. “These data add to the remarkable progress we’ve seen over the past five years in treating B-cel
Oulu2026 – European Capital of Culture: Oulu to Unveil Full European Capital of Culture 2026 Programme – Live Stream on 4 September 202529.8.2025 11:46:00 EEST | Press release
Hundreds of partners are creating a year in which Northern Finland becomes a new hub of culture. The programme will offer something for everyone: large-scale exhibitions, festivals across all genres, world premieres, performing arts, village celebrations, permanent artworks, sports, and community events across a vast region of 40 municipalities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250829591577/en/ Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. The Oulu2026 programme is built around the theme of Cultural Climate Change, meaning a lasting enrichment of cultural life – connecting people through world-class experiences, creativity, and new ways of thinking. “2026 will be a transformative year – for our city, for Northern Finla
Nippon Sanso Holdings Group Unifies Global Brand Logo Launching the "NIPPON SANSO" Brand Worldwide29.8.2025 09:00:00 EEST | Press release
Nippon Sanso Holdings Corporation (President CEO: Toshihiko Hamada) will unify the brand logo for its industrial gas business globally and implement the change in stages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828253560/en/ Until now, our group has operated industrial gas businesses worldwide using the same symbol mark, while adapting to each region. To further enhance recognition and understanding of our group as a unified entity among a broad range of stakeholders, and to maximize corporate value and achieve sustainable growth, we have decided to unify the brand for our industrial gas businesses as "NIPPON SANSO" and standardize the brand logo globally. Moving forward, we will continue striving to be a trusted company for all stakeholders as a globally recognized brand. *Please note that Thermos Group, which operates the consumer household goods business within our group, will not change its brand logo. *The log
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom